Clinical trial
Renasight Clinical Application, Review and Evaluation (RenaCARE) Study
NCT05846113 is registered in ClinicalTrials.gov with Natera, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Renasight Clinical Application, Review and Evaluation (RenaCARE) Study
- Lead sponsor
- Natera, Inc.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 7, 2021
- Completion date
- August 31, 2025
- Enrollment
- 1,720 (actual)
- Sites
- 31
Conditions
As the registry lists them; a condition with its own page is linked.